Sign In
Buy OGN
$13.40
+0.0200 (+0.149%)
At Close: Jun 03, 2026
Organon & Co. (OGN) Q3 2024 Earnings Call Transcript
12:28pm, Thursday, 31'st Oct 2024
Organon & Co. (NYSE:OGN ) Q3 2024 Earnings Call Transcript October 31, 2024 8:30 AM ET Company Participants Jennifer Halchak - VP, IR Kevin Ali - CEO Juan Camilo Arjona Ferreira - Head of R&D Matt Wal
Organon (OGN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
11:30am, Thursday, 31'st Oct 2024
The headline numbers for Organon (OGN) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estim
Organon (OGN) Q3 Earnings and Revenues Beat Estimates
09:46am, Thursday, 31'st Oct 2024
Organon (OGN) came out with quarterly earnings of $0.87 per share, beating the Zacks Consensus Estimate of $0.85 per share. This compares to earnings of $0.87 per share a year ago.
Organon Reports Results for the Third Quarter Ended September 30, 2024
07:30am, Thursday, 31'st Oct 2024
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon Reports Q3 2024 Earnings.
Ahead of Organon (OGN) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
10:21am, Monday, 28'th Oct 2024
Evaluate the expected performance of Organon (OGN) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics
Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
09:25am, Monday, 28'th Oct 2024
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon expands dermatology capabilities through completion of Dermavant acquisition, including nonbiologic, non-steroidal VTAMA Cream, 1%.
Earnings Preview: Organon (OGN) Q3 Earnings Expected to Decline
11:06am, Thursday, 24'th Oct 2024
Organon (OGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Want $300 in Dividends Every Month? Invest $20,000 in Each of These 3 Stocks
04:40am, Thursday, 24'th Oct 2024
These dividend stocks all pay yields of around 6% and higher.
5 Stocks to Buy for a Harris Presidency
02:12pm, Monday, 21'st Oct 2024
The race for the White House is heating up and these five stocks are set to benefit if Kamala Harris claims victory.
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
10:06am, Monday, 21'st Oct 2024
Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Here's Why Organon (OGN) Gained But Lagged the Market Today
07:06pm, Monday, 14'th Oct 2024
In the closing of the recent trading day, Organon (OGN) stood at $18.10, denoting a +0.56% change from the preceding trading day.
Organon (OGN) Loses -9.91% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
10:35am, Wednesday, 09'th Oct 2024
Organon (OGN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates co
Organon to Report Third Quarter 2024 Results and Host Conference Call on October 31, 2024
07:30am, Wednesday, 09'th Oct 2024
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN), a global healthcare company with a focus on women's health, will release its third quarter 2024 financial results on October 31, 2024, prior to
Organon (OGN) Stock Falls Amid Market Uptick: What Investors Need to Know
07:06pm, Tuesday, 08'th Oct 2024
Organon (OGN) closed at $18.10 in the latest trading session, marking a -0.11% move from the prior day.
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Tuesday, 08'th Oct 2024
Organon (OGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
